课题基金 / 基金详情

Histone chaperones and cell state regulation

Histone chaperones and cell state regulation
组蛋白伴侣和细胞状态调节
批准号:
10886880
负责人:
Amanda Rietta Wasylishen
金额:
$47.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-01 至 2024-08-31

项目摘要

项目成果

Amanda Rietta Wasylishen的其他基金

相似基金

相关文献

中文摘要
翻译
修改的项目摘要/摘要部分
英文摘要
Modified Project Summary/Abstract Section Homeostasis represents an essential balance between adjusting to changing conditions and maintaining overall stability, with perturbations contributing to diseases including diabetes, pancreatitis and cancers. Epigenetic mechanisms are central to homeostasis, including histone variants and the chaperone complexes that mediate their deposition. Histone 3.3 (H3.3) is a replacement variant for canonical histone H3 and is deposited in heterochromatin by a complex containing DAXX and ATRX. The importance of this epigenetic regulatory axis is emphasized by the early embryonic lethality of mice when any component is deleted, and recurrent somatic mutations in human cancers. This includes mutually exclusive loss-of-function mutations in DAXX or ATRX in 43% of pancreatic neuroendocrine tumors. The understanding of the physiologic functions of this regulatory complex and its component parts remains in its infancy. Emerging evidence indicates individual components regulate cellular differentiation states, including contributing to the establishment and maintenance of induced pluripotent stem cells in vitro and safeguarding hematopoietic stem cells against inappropriate differentiation in vivo. Recent work by the PI demonstrates that Daxx restricts cellular plasticity in the pancreas and maintains endogenous retroviral (ERV) silencing in vivo. This leads to the central hypothesis: As a regulator of H3.3 and heterochromatin, Daxx enforces a robust chromatin landscape that is important for the maintenance of transcriptional states and differentiation programs. The proposed studies in this project will combine comprehensive molecular and cellular analysis to dissect how Daxx regulates the epigenome, impacts gene expression, and contributes to physiologic cell state. This project will: Define Daxx-dependent regulation of the epigenome in vivo (Aim 1); and Elucidate Daxx-dependent cell state changes in a time course of pancreatic injury and recovery in vivo (Aim 2). Two new mouse models have recently been generated by the PI that abrogate the Daxx:Atrx and Daxx:H3.3 interactions respectively and subsequent studies will incorporate these innovative separation-of-function alleles to further dissect the DAXX/ATRX/H3.3 axis. Additionally, as mounting data suggests ERV repression is an important physiological function of Daxx and acknowledging the differences in repeat genomes between species, the proposed work will determine how DAXX loss affects transcriptional and cell state programs in the context of a human genome (Aim 3). Collectively, this project proposes an innovative research program that integrates powerful genetic models with comprehensive epigenomic and transcriptomic profiling to provide direct mechanistic insight into how the Daxx/Atrx/H3.3 complex contributes to chromatin maintenance and dynamics, and how perturbations impact downstream transcriptional and phenotypic states. Collectively, this work contributes to the project’s long-term goal of understanding the molecular mechanisms that maintain cellular identity and homeostasis, and the downstream pathological consequences when these mechanisms are lost.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The DAXX/ATRX/H3.3 axis in ERV regulation and tumor suppression
  • 批准号:
    10556315
  • 项目类别:
  • 资助金额:
    $19.12万
  • 财政年份:
    2022
  • 负责人:
    Amanda Rietta Wasylishen
  • 依托单位:
海外基金